Duke Cancer Institute professor participating in Smithsonian "Birth of Biotech" webchat
Dr. Kimberly L. Blackwell, head of the breast cancer program at the Duke Cancer Institute, will be one of four distinguished panel members who will discuss the future of the nation's biotechnology industry as part of the opening ceremonies for a new Smithsonian exhibit about biotech.
The panel on Oct. 24, hosted by biotech company Genentech and the Smithsonian National Museum of American History, will examine the impact of biotechnology on medicine and science and what we can expect from the industry in the years to come, according to Duke Medicine.
The other panelists include:
- Arthur D. Levinson, chairman of the board, Genentech, and the chairman of the board, Apple
- George M. Church, Robert Winthrop professor of genetics, Harvard Medical School
- Daniel Kraft, executive director, FutureMed
The moderator will be Matt Herper, senior editor of Forbes.
Blackwell was recently named one of TIME magazine's 100 most influential people.
"The more options we have enhance my ability to approach patients' treatment in the way they feel most comfortable," said Blackwell in an essay about personalized medicine. "Personalizing treatment is about treating the whole patient."
- What: "Celebrate the Birth of Biotech" webchat
- When: Oct. 24, 7 p.m. EST
- Visit the Genentech website for more information and to view the live stream for the hour-long web event.
- Tweet questions/comments to #DNAeffect during the webcast.
Have college/university news you'd like to share? Email higher ed reporter April Dudash at email@example.com. Follow her on Twitter @AD_HeraldSun.